BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33314699)

  • 1. Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis.
    Amkreutz JAMP; de Moel EC; Theander L; Willim M; Heimans L; Nilsson JÅ; Karlsson MK; Huizinga TWJ; Åkesson KE; Jacobsson LTH; Allaart CF; Turesson C; van der Woude D
    Arthritis Rheumatol; 2021 Jun; 73(6):921-930. PubMed ID: 33314699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
    Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R
    Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target.
    Bugatti S; Bogliolo L; Manzo A; De Stefano L; Delvino P; Motta F; Montecucco C
    Front Immunol; 2021; 12():701922. PubMed ID: 34194443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients.
    Regueiro C; Ortiz AM; Boveda MD; Castañeda S; Gonzalez-Alvaro I; Gonzalez A
    PLoS One; 2018; 13(8):e0202583. PubMed ID: 30118518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients.
    Orsolini G; Caimmi C; Viapiana O; Idolazzi L; Fracassi E; Gatti D; Adami G; Rossini M
    Calcif Tissue Int; 2017 Jul; 101(1):17-23. PubMed ID: 28246933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
    Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
    Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
    Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
    Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.
    Llorente I; Merino L; Ortiz AM; Escolano E; González-Ortega S; García-Vicuña R; García-Vadillo JA; Castañeda S; González-Álvaro I
    Rheumatol Int; 2017 May; 37(5):799-806. PubMed ID: 28243799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort.
    Hafström I; Ajeganova S; Forslind K; Svensson B
    Arthritis Res Ther; 2019 Feb; 21(1):45. PubMed ID: 30717793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between wrist bone mineral density and synovitis, erosion by ultrasonography in female rheumatoid arthritis patients].
    Wang Y; Geng Y; Deng XR; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):774-80. PubMed ID: 26474614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.
    Regueiro C; Rodriguez-Rodriguez L; Triguero-Martinez A; Nuño L; Castaño-Nuñez AL; Villalva A; Perez-Pampin E; Lopez-Golan Y; Abasolo L; Ortiz AM; Herranz E; Pascual-Salcedo D; Martínez-Feito A; Boveda MD; Gomez-Reino JJ; Martín J; Gonzalez-Escribano MF; Fernandez-Gutierrez B; Balsa A; Gonzalez-Alvaro I; Gonzalez A
    Arthritis Rheumatol; 2019 Mar; 71(3):331-339. PubMed ID: 30277011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA rheumatoid factor is associated with bone mineral density preservation in rheumatoid arthritis.
    Sghiri R; Boumiza A; Benhassine H; Elamri N; Shakoor Z; Slama F; Almogren A; Harrabi I; Sahli J; Guaddah L; Zeglaoui H; Bouajina E
    Clin Rheumatol; 2021 Dec; 40(12):4879-4887. PubMed ID: 34282512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.
    Hecht C; Englbrecht M; Rech J; Schmidt S; Araujo E; Engelke K; Finzel S; Schett G
    Ann Rheum Dis; 2015 Dec; 74(12):2151-6. PubMed ID: 25115448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
    Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
    Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
    Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
    RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.
    Wu CY; Yang HY; Luo SF; Lai JH
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials.
    Aletaha D; Alasti F; Smolen JS
    Arthritis Res Ther; 2015 Aug; 17(1):229. PubMed ID: 26307354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
    van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
    Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
    Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
    Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines).
    Westra J; Brouwer E; Raveling-Eelsing E; Arends S; Eman Abdulle A; Roozendaal C; van Delft MAM; Toes REM; Trouw LA; Vissink A; de Smit MJ
    Rheumatology (Oxford); 2021 Feb; 60(2):658-666. PubMed ID: 32594174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.